Commit Biologics (“Commit”), a biotechnology company pioneering complement system activation and backed by €21.5 million in ...

For years, patients with C3G and IC-MPGN had few options to stop the progression toward kidney failure. Now a new class of FDA-approved C3 inhibitors that targets the root of the complement system can ...

Our immune system works day and night to protect us from bacteria, viruses, and injuries. It is a complex defense network made up of many types of cells and proteins that cooperate to keep the body ...

Complement 3 glomerulopathy (C3G) is diagnosed with a combination of a clinical evaluation, blood tests, urine tests, and a renal (kidney) biopsy. The only way to definitively diagnose C3G and its ...

TEMPO.CO, Jakarta - Research results show the benefits of using supplement products in helping maintain the body's immune ...

Commit Biologics, a biotech company pioneering complement system activation, has appointed Thomas Montgomery Andresen as Chief Executive Officer (CEO), effective 16 March 2026. Thomas, a biotech ...

Researchers at the University of California San Diego and La Jolla Institute of Immunology have reported a preclinical immunotherapy strategy that redirected pre-existing cytomegalovirus-specific ...

He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...

Creative Biolabs expands its research capabilities, offering diversified tools and services to support global biomedical innovation. SHIRLEY, NY, UNITED STATES ...